Neoss Implant System 64082Recalls & reported problems
Neoss AB · NeoGen Cape Spacer 0.7 mm, Neoss NP · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 05060440335556), received between Aug 21, 2024 and Aug 21, 2024 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Hemorrhage/Blood Loss/Bleeding1
- Vomiting1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryAug 21, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ACCORDING TO THE REPORTER, THE PATIENT DEVELOPED A MAJOR BLEED FOLLOWING RADIO FREQUENCY ABLATION TREATMENT ON THE (B)(6) PRESENTED TO HOSPITAL WITH C/O VOMITING BLOOD (ABOUT 1 PINT) A WEEK AFTER HAVING HALOTHERAPY. ALSO, C/O FEELING SHORT OF BREATH AND BEING NAUSEOUS, WITH SOME EPIGASTRIC PAIN, AND HAVING BLACK STOOLS. ON EXAMINATION HE WAS QUITE PALE, AND HEMODYNAMICALLY UNSTABLE. PATIENT WAS RESUSCITATED WITH BLOOD AND PLASMA TRANSFUSION AND WAS TREATED WITH IV PPI AND WAS TAKEN FOR URGENT OGD, WHICH SHOWED A LARGE UGI BLEED SECONDARY TO ULCER, AND WAS ENDO-CLIPPED. TWO DAYS POST-OPERATIVE, THE PATIENT WAS ADMITTED TO A LOCAL HOSPITAL¿S INTENSIVE THERAPY UNIT WITH A MAJOR BLEED. THE PATIENT UNDERWENT ANOTHER RADIO FREQUENCY ABLATION ON THE (B)(6) TO TREAT (B)(6) OESOPHAGUS AND DEVELOPED ANOTHER MAJOR BLEED ON THE (B)(6), LEADING TO ANOTHER HOSPITAL ADMISSION. AS OF THE (B)(6), THE PATIENT WAS STILL IN THE INTENSIVE THERAPY UNIT. NOTHING ABNORMAL WAS NOTED DURING THE RADIO FREQUENCY ABLATION OR IMMEDIATELY AFTER THE PROCEDURE. A NEW CATHETER WAS USED FOR EACH ABLATION. THE TECHNIQUE USED TO ABLATE THE TISSUE WAS (B)(6) 2024 C10 M10 30-40 CM TREATED WITH CIRCUMFERENTIAL (APP, SCRA
Patient problems: Hemorrhage/Blood Loss/Bleeding; Vomiting
MAUDE report 20012315 ↗
Other Screw, Fixation, Intraosseous devices
- MatrixMIDFACE 04.503.226.01Synthes GmbH · SCREW, FIXATION, INTRAOSSEOUS21 reports
- NA 400.736ESynthes GmbH · SCREW, FIXATION, INTRAOSSEOUS21 reports
- OsteoMed 204-1206Osteomed LLC · SCREW, FIXATION, INTRAOSSEOUS14 reports
- NA 201.928Synthes GmbH · SCREW, FIXATION, INTRAOSSEOUS14 reports
- LEVEL ONE CMF 25-092-12-91KLS-Martin L.P. · SCREW, FIXATION, INTRAOSSEOUS11 reports
- LEVEL ONE CMF 25-092-08-91KLS-Martin L.P. · SCREW, FIXATION, INTRAOSSEOUS9 reports
- OsteoMed 202-2016Osteomed LLC · SCREW, FIXATION, INTRAOSSEOUS9 reports
- MatrixMIDFACE 04.503.204.01Synthes GmbH · SCREW, FIXATION, INTRAOSSEOUS8 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page